相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison
Daniel Villela et al.
CLINICAL SCIENCE (2015)
Neuroprotective Effects of Angiotensin Receptor Blockers
Sonia Villapol et al.
AMERICAN JOURNAL OF HYPERTENSION (2015)
Interaction Between NADPH-Oxidase and Rho-Kinase in Angiotensin II-Induced Microglial Activation
Ana I. Rodriguez-Perez et al.
GLIA (2015)
Low-Dose Candesartan Enhances Molecular Mediators of Neuroplasticity and Subsequent Functional Recovery After Ischemic Stroke in Rats
Tauheed Ishrat et al.
MOLECULAR NEUROBIOLOGY (2015)
LPS antagonism of TGF-β signaling results in prolonged survival and activation of rat primary microglia
Kendall Mitchell et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward: Report of the Department of Defense Neurotrauma Pharmacology Workgroup
Ramon Diaz-Arrastia et al.
JOURNAL OF NEUROTRAUMA (2014)
Strong Improvement of Apolipoprotein E/Low-Density Lipoprotein eceptor Signals by Telmisartan in Poststroke Spontaneously Hypertensive Stroke Resistant
Toru Yamashita et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
Protective Effect of Telmisartan Against Progressive Oxidative Brain Damage and Synuclein Phosphorylation in Stroke-resistant Spontaneously Hypertensive Rats
Yusuke Fukui et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke
Jason P. Joseph et al.
NEUROPHARMACOLOGY (2014)
Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT1 receptor blockade and PPARγ activation
Juan Wang et al.
NEUROPHARMACOLOGY (2014)
Angiotensin Receptor Type 2 Activation Induces Neuroprotection and Neurogenesis After Traumatic Brain Injury
Gali Umschweif et al.
NEUROTHERAPEUTICS (2014)
Very Early Administration of Progesterone for Acute Traumatic Brain Injury
David W. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Non-hypotensive dose of telmisartan and nimodipine produced synergistic neuroprotective effect in cerebral ischemic model by attenuating brain cytokine levels
A. Justin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Temporal dynamics of cerebral blood flow, cortical damage, apoptosis, astrocyte vasculature interaction and astrogliosis in the pericontusional region after traumatic brain injury
Sonia Villapol et al.
FRONTIERS IN NEUROLOGY (2014)
Candesartan Induces a Prolonged Proangiogenic Effect and Augments Endothelium-Mediated Neuroprotection after Oxygen and Glucose Deprivation: Role of Vascular Endothelial Growth Factors A and B
Sahar Soliman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Angiotensin-Receptor Blockers and Risk of Alzheimer's Disease in Hypertension Population - A Nationwide Cohort Study
Chien-Yi Hsu et al.
CIRCULATION JOURNAL (2013)
Protective arms of the renin-angiotensin-system in neurological disease
Colin Sumners et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
Antihypertensive Therapy and Cerebral Hemodynamics in Executive Mild Cognitive Impairment: Results of a Pilot Randomized Clinical Trial
Ihab Hajar et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2013)
Expression of angiotensin II and its receptors in activated microglia in experimentally induced cerebral ischemia in the adult rats
Chun-Yun Wu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
Martin C. Michel et al.
PHARMACOLOGICAL REVIEWS (2013)
AT1 Receptor Antagonism Is Proangiogenic in the Brain: BDNF a Novel Mediator
Ahmed Alhusban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Evaluation of the Relationship between Sex, Polymorphisms in CYP2C8 and CYP2C9, and Pharmacokinetics of Angiotensin Receptor Blockers
Teresa Cabaleiro et al.
DRUG METABOLISM AND DISPOSITION (2013)
RAS Inhibition Attenuates Cognitive Impairment by Reducing Blood-Brain Barrier Permeability in Hypertensive Subjects
Nicolas Pelisch et al.
CURRENT HYPERTENSION REVIEWS (2013)
Therapeutic Approach for Neuronal Disease by Regulating Renin-angiotensin System
Kousei Ohshima et al.
CURRENT HYPERTENSION REVIEWS (2013)
Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series
Ihab Hajjar et al.
ARCHIVES OF NEUROLOGY (2012)
Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention
Alok Kumar et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders
Juan M. Saavedra
CLINICAL SCIENCE (2012)
A Review of Neuroprotection Pharmacology and Therapies in Patients with Acute Traumatic Brain Injury
Kevin W. McConeghy et al.
CNS DRUGS (2012)
Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma
Ralph Timaru-Kast et al.
CRITICAL CARE MEDICINE (2012)
Angiotensin II type 2 receptor agonists - where should they be applied?
Ulrike Muscha Steckelings et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease
Pablo Garrido-Gil et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice
Sonia Villapol et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques
Akihiro Noda et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
Julius Benicky et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Vascular Protection by Angiotensin Receptor Antagonism Involves Differential VEGF Expression in Both Hemispheres after Experimental Stroke
Weihua Guan et al.
PLOS ONE (2011)
Brain renin-angiotensin-A new look at an old system
John W. Wright et al.
PROGRESS IN NEUROBIOLOGY (2011)
Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia
Yukiko Kasahara et al.
BRAIN RESEARCH (2010)
Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties
Sylvia Deppe et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury
Teuntje M. J. C. Andriessen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
ANGIOTENSIN II INDUCED CEREBRAL MICROVASCULAR INFLAMMATION AND INCREASED BLOOD-BRAIN BARRIER PERMEABILITY VIA OXIDATIVE STRESS
M. Zhang et al.
NEUROSCIENCE (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Unilateral Blood Flow Decrease Induces Bilateral and Symmetric Responses in the Immature Brain
Sonia Villapol et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Candesartan improves memory decline in mice: Involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin
Santoshkumar Tota et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Cognitive Deficit in Amyloid-β-Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
Kana Tsukuda et al.
HYPERTENSION (2009)
Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats
Emi Omura-Matsuoka et al.
HYPERTENSION RESEARCH (2009)
Angiotensin II modulates BBB permeability via activation of the AT1 receptor in brain endothelial cells
Melissa A. Fleegal-DeMotta et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
EXPRESSION OF ANGIOTENSIN II AND ITS RECEPTORS IN THE NORMAL AND HYPOXIC AMOEBOID MICROGLIAL CELLS AND MURINE BV-2 CELLS
J. J. Li et al.
NEUROSCIENCE (2009)
Candesartan Augments Ischemia-Induced Proangiogenic State and Results in Sustained Improvement After Stroke
Anna Kozak et al.
STROKE (2009)
A Systematic Review of Angiotensin Receptor Blockers in Preventing Stroke
Guo-Cai Lu et al.
STROKE (2009)
Telmisartan prevented cognitive decline partly due to PPAR-γ activation
Masaki Mogi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Ramya Kapadia et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies
Hao Liu et al.
JOURNAL OF HYPERTENSION (2008)
Vascular protection with candesartan after experimental acute stroke in hypertensive rats: A dose-response study
Wieslaw Kozak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral Hemorrhage
Keun-Hwa Jung et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
AT1 receptor blocker candesartan-induced attenuation of brain injury of rats subjected to chronic cerebral hypoperfusion
Veysel Haktan Ozacmak et al.
NEUROCHEMICAL RESEARCH (2007)
Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPAR-γ
Stefan Zorad et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
PPAR:: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases
R. Bordet et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress
Meiko Hamai et al.
NEUROPHARMACOLOGY (2006)
AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats
J Zhou et al.
STROKE (2006)
Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - A review
A Zanchetti et al.
BLOOD PRESSURE (2006)
Angiotensin II: multitasking in the brain
Juan M. Saavedra et al.
JOURNAL OF HYPERTENSION (2006)
Brain angiotensin II: New developments, unanswered questions and therapeutic opportunities
JM Saavedra
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
A putative placebo comparison of the SCOPE and LIFE trials
PA Meredith et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2004)
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-α activity
M Schupp et al.
CIRCULATION (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Influence of losartan and atenolol on memory function in very elderly hypertensive patients
R Fogari et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
Angiotensin II is associated with activation of NF-κB-mediated genes and downregulation of PPARs
DM Tham et al.
PHYSIOLOGICAL GENOMICS (2002)
Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist
T Ito et al.
STROKE (2002)
Increased angiotensin II AT1 receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT2 receptor gene disrupted mice
I Armando et al.
NEUROENDOCRINOLOGY (2002)
Clinical pharmacokinetics of candesartan
CH Gleiter et al.
CLINICAL PHARMACOKINETICS (2002)
Chronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1 receptors
Y Nishimura et al.
BRAIN RESEARCH (2000)
分享论文
